共 50 条
Race and Genetics in Congenital Heart Disease: Application of iPSCs, Omics, and Machine Learning Technologies
被引:24
作者:
Mullen, McKay
[1
,2
]
Zhang, Angela
[1
,3
]
Lui, George K.
[1
,4
]
Romfh, Anitra W.
[1
,3
,5
]
Rhee, June-Wha
[1
,3
]
Wu, Joseph C.
[1
,3
,6
]
机构:
[1] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA
[2] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA
[3] Stanford Univ, Dept Genet, Stanford Sch Med, Stanford, CA 94305 USA
[4] Stanford Univ, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA
[5] Stanford Univ, Dept Pediat, Div Pediat Cardiol, Stanford, CA 94305 USA
[6] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA
来源:
FRONTIERS IN CARDIOVASCULAR MEDICINE
|
2021年
/
8卷
基金:
美国国家卫生研究院;
关键词:
congenital heart disease;
iPSC;
disease modeling;
genomics;
race;
disparity;
D O I:
10.3389/fcvm.2021.635280
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Congenital heart disease (CHD) is a multifaceted cardiovascular anomaly that occurs when there are structural abnormalities in the heart before birth. Although various risk factors are known to influence the development of this disease, a full comprehension of the etiology and treatment for different patient populations remains elusive. For instance, racial minorities are disproportionally affected by this disease and typically have worse prognosis, possibly due to environmental and genetic disparities. Although research into CHD has highlighted a wide range of causal factors, the reasons for these differences seen in different patient populations are not fully known. Cardiovascular disease modeling using induced pluripotent stem cells (iPSCs) is a novel approach for investigating possible genetic variants in CHD that may be race specific, making it a valuable tool to help solve the mystery of higher incidence and mortality rates among minorities. Herein, we first review the prevalence, risk factors, and genetics of CHD and then discuss the use of iPSCs, omics, and machine learning technologies to investigate the etiology of CHD and its connection to racial disparities. We also explore the translational potential of iPSC-based disease modeling combined with genome editing and high throughput drug screening platforms.
引用
收藏
页数:9
相关论文
共 50 条